BE849897A - Vaccins vivants contre la varicelle et le zona - Google Patents

Vaccins vivants contre la varicelle et le zona

Info

Publication number
BE849897A
BE849897A BE173669A BE173669A BE849897A BE 849897 A BE849897 A BE 849897A BE 173669 A BE173669 A BE 173669A BE 173669 A BE173669 A BE 173669A BE 849897 A BE849897 A BE 849897A
Authority
BE
Belgium
Prior art keywords
zona
vaccines
live varicella
varicella
live
Prior art date
Application number
BE173669A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE849897A publication Critical patent/BE849897A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/25—Varicella-zoster virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16761—Methods of inactivation or attenuation
    • C12N2710/16763—Methods of inactivation or attenuation by chemical treatment
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/821—Drug, bio-affecting and body treating compositions involving temperature-sensitive mutant virus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BE173669A 1975-12-29 1976-12-28 Vaccins vivants contre la varicelle et le zona BE849897A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/644,787 US4008317A (en) 1975-12-29 1975-12-29 Varicella-zoster virus vaccine and preparation thereof

Publications (1)

Publication Number Publication Date
BE849897A true BE849897A (fr) 1977-06-28

Family

ID=24586321

Family Applications (1)

Application Number Title Priority Date Filing Date
BE173669A BE849897A (fr) 1975-12-29 1976-12-28 Vaccins vivants contre la varicelle et le zona

Country Status (6)

Country Link
US (1) US4008317A (fr)
JP (1) JPS5282721A (fr)
BE (1) BE849897A (fr)
DE (1) DE2655691C2 (fr)
FR (1) FR2336944A1 (fr)
GB (1) GB1565830A (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57500149A (fr) * 1980-01-25 1982-01-28
US4315914A (en) * 1980-04-04 1982-02-16 Seiji Arakawa Pharmaceutical compositions useful as cellular immunopotentiator and antitumor agent and process for production thereof
US4714678A (en) * 1982-10-13 1987-12-22 Smithkline-Rit Temperature sensitive strain of bovine viral diarrhoea virus
IT1213254B (it) * 1984-12-06 1989-12-14 Boehringer Biochemia Srl Metodo diagnostico per la valutazione di parametri clinici mediante prelievo diretto dimateriali biologici e dispositivoper la sua attuazione.
WO1992006989A1 (fr) 1990-10-04 1992-04-30 Research Corporation Technologies, Inc. Antigene d'herpes virus varicellae
US5824319A (en) * 1990-10-04 1998-10-20 Research Corporation Technologies, Inc. Varicella-zoster virus antigen
PT651789E (pt) * 1992-07-17 2002-05-31 Merck & Co Inc Metodo para a prevencao de zoster ou alivio de neuralgia pos-herpetica relacionada com varicela
AU2158995A (en) 1994-03-15 1995-10-03 Medical College Of Pennsylvania And Hahnemann University Compositions and methods for vaccines comprising alpha-galactosyl epitopes
US7666082B2 (en) * 2004-05-07 2010-02-23 Gamelogic Inc. Method and apparatus for conducting a game of chance
WO2015034807A2 (fr) 2013-09-05 2015-03-12 Merck Sharp & Dohme Corp. Procédés d'immunisation par l'antigène du virus varicelle-zona

Also Published As

Publication number Publication date
DE2655691C2 (de) 1985-08-14
JPS624370B2 (fr) 1987-01-30
US4008317A (en) 1977-02-15
FR2336944B1 (fr) 1980-07-18
GB1565830A (en) 1980-04-23
DE2655691A1 (de) 1977-07-14
FR2336944A1 (fr) 1977-07-29
JPS5282721A (en) 1977-07-11

Similar Documents

Publication Publication Date Title
BE878430A (fr) Vaccins contre la pasteurellose
DK293575A (da) Triazolyl-alkanoner og -alkanoler samt fremgangsmade til deres fremstilling og deres anvendelse
BE786240Q (fr) Vaccin contre l'hepatite virale et sa preparation
DK455880A (da) Stabiliseret vaccine og vaccinestabilisator
FR2316201A1 (fr) Similigranite et sa preparation
BE805570A (fr) Vaccins et leur preparation
BE858992A (fr) Procede de preparation de vaccins
DK218175A (da) Peptider med lh-rh/fsh-rh-virkning og fremgangsmade til deres fremstilling
AU504454B2 (en) Hepatitis b antigen and vaccine
BE851880A (fr) Vaccins vivants ameliores contre la pseudopeste aviaire
DK211775A (da) Substituerede phenylguanidiner samt deres fremstilling og anvendelse
FR2336944A1 (fr) Vaccins vivants contre la varicelle et le zona
DK287476A (da) Pyrrolidoner samt deres fremstilling og anvendelse
DK539979A (da) Quinazolinonderivater samt deres fremstilling og anvndelse
NL7804660A (nl) Verbeterde vaccins.
ZA786664B (en) Pneumococcal vaccine
DK353575A (da) 1-thiadiazolylimidazolidinoner samt deres fremstilling og anvendelse
BE846681A (fr) Preparations biologiques
BE832967A (fr) Vaccins contre les enterites
BE808708A (fr) Vaccins vivants contre la rhinotracheite infectieuse bovine et leur preparation
IT7867143A0 (it) Vaccino e procedimento per lasua preparazione
DK474678A (da) Halogenvinyl-gamma-butyrolactoner samt deres fremstilling og anvendelse
CA943501A (en) Pole holding and setting device
DK286480A (da) Oxinethere deres fremstilling og anvendelse
BE824372A (fr) Vaccins antigrippaux et procede de leur preparation

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: SMITH KLINE RIT

Effective date: 19881231